| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
73,690,000 |
| Market
Cap: |
172.43(M) |
| Last
Volume: |
576,427 |
Avg
Vol: |
574,826 |
| 52
Week Range: |
$1.42 - $3.2 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 9.1 |
| Insider 3/6 Months : 9.7 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Stereotaxis designs, manufactures and markets robotic systems, instruments and information systems for the interventional laboratory. Co.'s products include: Genesis RMN System and Niobe System, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; Odyssey Solution, which provides an integrated, real-time information solution to manage, control, record and share procedures across networks; and Stereotaxis Imaging Model S x-ray System, which provides an integrated solution for a robotic interventional operating room.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
86,886 |
182,579 |
466,210 |
| Total Buy Value |
$0 |
$131,500 |
$287,984 |
$804,792 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
10 |
24 |
34 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Duros Karen Witte |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2018-02-12 |
4 |
D |
$0.74 |
$1,410 |
D/D |
(1,905) |
59,263 |
|
- |
|
| Brathwaite Paul |
VP Research & Development |
• – – |
2018-02-12 |
4 |
D |
$0.76 |
$1,410 |
D/D |
(1,855) |
37,442 |
|
- |
|
| Stammer Martin C |
Chief Financial Officer |
• – – |
2018-02-12 |
4 |
D |
$0.75 |
$3,672 |
D/D |
(4,896) |
101,359 |
|
- |
|
| Brathwaite Paul |
VP Research & Development |
• – – |
2018-02-07 |
4 |
D |
$0.75 |
$515 |
D/D |
(687) |
39,297 |
|
- |
|
| Duros Karen Witte |
Sr. VP, Gen. Counsel & Sec. |
• – – |
2018-02-07 |
4 |
D |
$0.75 |
$515 |
D/D |
(687) |
61,168 |
|
- |
|
| Stammer Martin C |
Chief Financial Officer |
• – – |
2018-02-07 |
4 |
D |
$0.75 |
$1,348 |
D/D |
(1,797) |
106,255 |
|
- |
|
| Kiani Joe E |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
80,000 |
|
- |
|
| Menawat Arun Swarup |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
235,439 |
|
- |
|
| Fischel David Leo |
Chief Executive Officer |
• • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
80,000 |
|
- |
|
| Messey Robert J |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
115,818 |
|
- |
|
| Middleton Fred A |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
149,682 |
|
- |
|
| Fischel Nathan |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
74,500 |
|
- |
|
| Benfer David |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
128,714 |
|
- |
|
| Middleton Fred A |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
119,682 |
|
- |
|
| Fischel Nathan |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
44,500 |
|
- |
|
| Kiani Joe E |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
50,000 |
|
- |
|
| Messey Robert J |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
85,818 |
|
- |
|
| Menawat Arun Swarup |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
205,439 |
|
- |
|
| Fischel David Leo |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
50,000 |
|
- |
|
| Benfer David |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
98,714 |
|
- |
|
| Brathwaite Paul |
VP Research & Development |
• – – |
2017-03-29 |
4 |
D |
$0.55 |
$1,617 |
D/D |
(2,926) |
39,984 |
|
- |
|
| Stammer Martin C |
Chief Financial Officer |
• – – |
2017-03-29 |
4 |
D |
$0.55 |
$2,540 |
D/D |
(4,595) |
108,052 |
|
- |
|
| Duros Karen Witte |
Sr. VP, Gen. Counsel and Sec. |
• – – |
2017-03-29 |
4 |
D |
$0.55 |
$1,617 |
D/D |
(2,926) |
61,855 |
|
- |
|
| Giffin David |
VP, Human Resources |
• – – |
2017-03-29 |
4 |
D |
$0.55 |
$1,617 |
D/D |
(2,926) |
62,512 |
|
- |
|
| Brathwaite Paul |
VP Research & Development |
• – – |
2017-03-28 |
4 |
D |
$0.53 |
$1,295 |
D/D |
(2,452) |
42,910 |
|
- |
|
285 Records found
|
|
Page 7 of 12 |
|
|
0.02 (0.86%) 
